Gefitinib (‘Iressa’), an epidermal growth factor receptor tyrosine kinase inhibitor, mediates the inhibition of lymph node metastasis in oral cancer cells
- 25 November 2003
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 201 (2) , 149-155
- https://doi.org/10.1016/s0304-3835(03)00464-6
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Expression of the αvβ6 Integrin Promotes Migration and Invasion in Squamous Carcinoma CellsJournal of Investigative Dermatology, 2001
- Tyrosine Kinase Inhibitors Targeted to the Epidermal Growth Factor Receptor SubfamilyDrugs, 2000
- Integrins α5β1, αvβ1, and αvβ6 Collaborate in Squamous Carcinoma Cell Spreading and Migration on FibronectinExperimental Cell Research, 2000
- The Epidermal Growth Factor Receptor and Its Inhibition in Cancer TherapyPharmacology & Therapeutics, 1999
- Levels of TGF-α and EGFR Protein in Head and Neck Squamous Cell Carcinoma and Patient SurvivalJNCI Journal of the National Cancer Institute, 1998
- Expression of epidermal growth factor receptor and human papillomavirus E6/E7 proteins in cervical carcinoma cellsJNCI Journal of the National Cancer Institute, 1997
- The Biologic Effects of C225, A Chimeric Monoclonal Antibody to the EGFR, on Human Prostate CarcinomaJournal of Immunotherapy, 1996
- Prognostic significance of transforming growth factor-α in human esophageal carcinoma implication for the autocrine proliferationCancer, 1993
- Signal transduction by integrin receptors for extracellular matrix: cooperative processing of extracellular informationCurrent Opinion in Cell Biology, 1992
- Integrins: Versatility, modulation, and signaling in cell adhesionCell, 1992